Over the course of this year, I will provide my views of the context for innovations (see prior post on areas of interest) from the perspective of these five healthcare stakeholders:

1. Biopharma manufacturers
2. Device & Diagnostics manufacturers
3. Health insurance companies
4. Self-insured employers
5. Health delivery networks

Conversations with investors, entrepreneurs, current and former colleagues have led me to a conclusion (unscientific, granted) that a major reason we don’t benefit from more impactful business innovations in our healthcare system and attracting talented innovators who can address poor return on investment of our health system is because the status quo is complex and not well understood. 

These series of posts, I hope, will play a small part in reducing complexity and attracting more talent and impactful ideas.  I anticipate the posts will offer high-level frameworks which can be expanded upon and explored in the comments or in separate posts where there is interest.